This program aims to identify inhibitors of the 4'-phosphopantetheinyltransferase (PPTase) PptT associated with mycolic acid production in Mycobacterium tuberculosis (Mtb). PptT is responsible for activation of mycolic acid synthase, an essential protein involved in the biosynthesis of the mycobacterial cell wall and a newly validated drug target. We have recently completed a high-throughput screening (HTS) effort to identify inhibitors against Sfp, the Bacillus subtilis surfactin PPTase, in collaboration with the NIH Chemical Genomics Center (NCGC). Here we seek to probe the hits identified in this screen for activity against PptT and evaluate their antibacterial activity against wild type and drug resistant Mtb strains. Given our preliminary results from the Sfp HTS effort, the development of a robust and general PPTase assay, the importance of this pathogen for drug development, and the recent validation of PptT as a druggable target with potential for antibiotic development, we anticipate discovery of a new class of antitubucular compounds within the timeframe of this project.

Public Health Relevance

Mycobacterium tuberculosis (Mtb) is the leading cause of death in the world from a bacterial infectious disease, affecting 1.8 billion people/year. This program examines the development of a new class of therapeutics that target the 4'-phosphopantetheinyltransferase (PPTase) PptT associated with mycolic acid production in Mycobacterium tuberculosis (Mtb) with the goal of identifying a panel of lead compounds within the funded period,

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section (DDR)
Program Officer
Boyce, Jim P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
Schools of Arts and Sciences
La Jolla
United States
Zip Code
Foley, Timothy L; Dorjsuren, Dorjbal; Dexheimer, Thomas S et al. (2016) A Platform to Enable the Pharmacological Profiling of Small Molecules in Gel-Based Electrophoretic Mobility Shift Assays. J Biomol Screen 21:1125-1131
Lindert, Steffen; Tallorin, Lorillee; Nguyen, Quynh G et al. (2015) In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors. J Comput Aided Mol Des 29:79-87
Tallorin, Lorillee C; Durrant, Jacob D; Nguyen, Quynh G et al. (2014) Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase. Bioorg Med Chem 22:6053-6061
Kosa, Nicolas M; Foley, Timothy L; Burkart, Michael D (2014) Fluorescent techniques for discovery and characterization of phosphopantetheinyl transferase inhibitors. J Antibiot (Tokyo) 67:113-20
Foley, Timothy L; Rai, Ganesha; Yasgar, Adam et al. (2014) 4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide (ML267), a potent inhibitor of bacterial phosphopantetheinyl transferase that attenuates secondary metabolism and thwarts bacterial growth. J Med Chem 57:1063-78
Kosa, Nicolas M; Haushalter, Robert W; Smith, Andrew R et al. (2012) Reversible labeling of native and fusion-protein motifs. Nat Methods 9:981-4
Foley, Timothy L; Yasgar, Adam; Garcia, Christopher J et al. (2010) Preparation of FRET reporters to support chemical probe development. Org Biomol Chem 8:4601-6
Foley, Timothy L; Young, Brian S; Burkart, Michael D (2009) Phosphopantetheinyl transferase inhibition and secondary metabolism. FEBS J 276:7134-45
Foley, Timothy L; Burkart, Michael D (2009) A homogeneous resonance energy transfer assay for phosphopantetheinyl transferase. Anal Biochem 394:39-47